Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × AML × ivosidenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 11 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Recurrence 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 IDH1-Mutated Malignancies 1 Hematologic Neoplasms 1 AML 1

Interventions

ivosidenib 1 Magnesium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06717958 2025-07-02

PIVOT

Technische Universität Dresden

Phase 2 Recruiting

AML

Data powered by HemOnc (CC BY 4.0) Colophon ⚡